Lékařská fakulta, Masarykova Univerzita
Yüklə 1,31 Mb.
|
| 87 (2001), pp. 493–496.
De Gramont, A., Bosset, J.F., Milan, C.: Randomised trial comparing monthly low-dose leucovorin and fluorouracil bolus with bomonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a french intergroup study. J. Clin. Oncol., 1997, 15, 808-815. De Gramont, A, Figer, A., Seymour, M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol., 2000, 18: 2938-2947 DeLaney TF, Smith AR, Lomax A, et al. Proton beam radiation therapy. Principles & Practice of Oncology Updates. Philadelphia, Pa: JB Lippincott; 2003;17:1-10 Dell’Agnola, C. & Biragyn, A. Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Rev. Vaccines 2007, 6, 267–283. Diebold SS, Kursa M, Wagner E, et al. Mannose Polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 1999; 274: 19087-19094 Dionigi R, MadariagaJ. New technologies for liver resection. 1th ed. Basel, Karger Landes systém 1997, 1-267 Dobson J. Key-note lecture: Applicaions of magnetic nanoparticles in biology and medicine. Presented at the New Frontiers in Nanomedicine. Hammersmith Hospital Conference center, London, October 2007 Dodd GD, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threashold of a major breakthrough. Radio Graphics 2000, 20: 9-27 Dodd GD, Frank MS, Aribandi M, et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlaping ablations. AJR 2001, 1777: 777-82 Donnenberg VS, Donnenberg AD.Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.J Clin Pharmacol 2005;45:872-7 Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000, 355: 1041-7 Drábková J. Účinky kapnoperitonea během laparoskopické cholecystektomie, Anesteziol, res. a IM 2001; 5:204-212 Duke Univerzity. Genomic Signatures of Drug Sensitivity Can Predict Response to Treatment J Clin Oncol. 2007;25:4350–4357. Elias D., Baere de T, Roche A., et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of liver parenchyma. Br J Surg 1999, 86: 784-8 Elias D, Youssef O, Sideris L et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 2004;86:4 –9. Ellis LM, Curley SA, Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 2005; 23:4853– 4855. Emens, L. A., Reilly, R. T. & Jaffee, E. M. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity. Endocr. Relat. Cancer 2005 12, 1–17. Faivre J, Rat P, Arveux P. Epidemiologie des metastases hepatiques des caners de colon. In Nordlinger B, Jaeck D (eds.). Traitment des metastases hepatiques des cancers colorectaux. Paris 1992, Springer Verlag,: 2-9 Farges O, Belghiti J, Kainmanesh R, et al. Portal vein embolization before right hepatecomy: prospective clinical trial. Ann Surg 2003, 237: 208-17 G. Ferzli, A. David and T. Kiel, Laparoscopic resection of a large hepatic tumor. Surg Endosc 9 (1995), pp. 733–735. Fire A, Xu S, Montgomery MK, et al. Nature 1998, 391: 806 Florek M et al. 2005, Cell Tissue Res 319: 15-26 Fong Y, Blumgart LH. Surgical options in the treatment of hepatic metastases for colorectal cancer. Curr Probl Surg 1996; 35:336–413 Fong Y, Kemeny N, Paty P, et al. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 1996;12:219–252. Fong Y, Cohen AM, Fortner J,G, et al. Liver resection on colorectal metastases. JCO 1997, 15: 938-46 Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309 –318; discussion 318–321. Franklin, R. J. M. et al. Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. NeuroReport 1999, 10, 1–5 Gabizon AA. Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy. Cancer Invest. 2001, 19, 424–436. M. Gagner, M. Rheault and J. Dubuc, Laparoscopic partial hepatectomy for liver tumor. Surg Endosc 6 (1992), p. 99. Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006). Gambhir, S. S. Molecular imaging of cancer with positron emisson tomography. Nature Rev. Cancer 2002, 2, 683–693. Garufi C, et al. Letter to the Editor. J Clin Oncol 2006, p.2217-2218 Gautam A, Densmore CL, Xu B, Waldrep JC. Mol. Ther. 2000, 2: 63. Gee, M. S. et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res. 2001, 61, 2974–2982. Geryk E, Kolcová V, Žáček V. Trendy počtů onkologických nemocných v České republice. Občanské sdružení podpory zdraví a onkologické prevence v Brně, Brno, 2000 Giacchetti, S., Perpoint, B., Zidani, R., et al. Phase III multicenter randomised trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J.Clin.Oncol. 2000, 18: 136-147 Gigot JF, D. Glineur, J. Santiago Azagra, M. Goergen, M. Ceuterick et al., Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 236 (2002), pp. 90–97. Gillams AR. Thermal ablation of liver metastases. Abdom Imaging 2001, 26: 361-8 Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004, 14: 2261-7 Glimelius B, Isacsson U, Blomquist E, et al. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol. 1999;38:137-145 Gloor B, Q. Ly and D. Candinas, Role of laparoscopy in hepatic cyst surgery. Dig Surg 19 6 (2002), pp. 494–499. Glunde, K., Jacobs, M. A. & Bhujwalla, Z. M. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev. Mol. Diag. 2006, 6, 821–829. Goin JE, Salem R, Carr BI et al. Treatment of unresectable hepatocellular carcinomas with intrahepatic yttrium-90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005, 16: 161-4 Goldberg SN, Stein M, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: optimization of pulsed RF technique to increase coagulation necrosis. J Vasc Interven Radiol 1999, 10: 907-16 Goldberg SN, Ahmed M, Gazelle GS, et al. Radiofrequency thermal ablation with NaCl solution injection: effect of elestrical conductivity on tissue heating and coagulation – phantom and porcine liver study. Radiology 2001, 219: 157-65 Goldberg RM, Sargent DJ, Morton RF, at al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated colorectal cancer. J Clin Oncol 2004, 22: 23-30 Golman, K., in ‘t Zandt, R. & Thaning, M. Real-time metabolic imaging. Proc. Natl Acad. Sci. USA 2006, 103, 11270–11275. Golman, K. & Petersson, J. S. Metabolic imaging and other applications of hyperpolarized 13C. Acad. Radiol. 2006, 13, 932–942. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58 Gottschalk S, Cristiano RJ, Smith LC, Woo SLC. Folate receptor-mediated DNA delivery into tumor cells: protosomal disruption results in enhanced gene expression. Gene Ther 2001; 1: 185-191 Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 mirospheres. Aust N Z J Surg 1992, 62: 105-10 Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients wih liver metastases from primary large bowel cancer. Ann Oncol 2001, 12: 1711-20 Griesmayer E, Auberger T. The status of MedAustron. Radiother. Oncol. 2004; 73Suppl 2:p202-5 Grosse S, Aron Y, Honore I, et al. Lactosylated polyethylenimine for gene transfer into airway epithelial cells: Role of the sugar moiety in cell delivery and intracellular trafficking of the complexes. J Gene Med 2004; 6: 345-356. Grothey A, Sargent D, Goldberg RM, et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004, 22: 1209-14 Gruenberger T, Sorbye H, DeboisMet al. Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM). Interim results of EORTC Intergroup randomized phase III study 40983. J Clin Oncol 2006;24(18 suppl):3500. Guo W, et al. Pediatr.Res. 2006, 59: 59R-64R Gyves J, Ensminger W, Niderhuber J, et al. : Totally implanted systém for intravenous chemotherapy in patients with cancer. Amer.J.Med., 73, 1982, p.841-5 Haddad FF, Chapman WC, Wright JK, et al. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998;75:103–108. Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol 2006;32:473– 483. Harewood, Baron, Rumala, Wang: Pilot study to Assess Patient outcomes Following Endoscopic Application of photodynamic Therapy for Advanced Cholangicarcinoma, JGH, 2005, 20(3), 415-420 Helmebeger T Holzknecht N, Schopf U, et al. Radiofrequency ablation of liver metastases. Technique and initial results. Radiologe 2001, 41: 69-76 Herba MJ, Thirlwell MP. Radioembolization for hepatic metastases. Semin Oncol 2002, 29: 152-9 Hiraki T, Kanazawa S. Hepatic outflow obstruction created by baloon occlusion of hepatic vein: induced hepatic hemodynamic changes and the therapeutic applications of hepatic venous occlusion with a baloon catheter in interventional radiology. Acta Medica Okayama 2005, 59: 171-8 Hirko A, Tang F, Hughes JA. Cationic lipid vectors for plasmid DNA delivery. CurMed Chem 2003; 10: 1185-1193 Holubec L jr, Sutnar A, Topolčan O, et al. Role adhezivních molekul v procesu metastazování u kolorektálního karcinomu. in Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater - Abstrakta. 1. vyd. Plzeň : Euroverlag s.r.o., 2003. s. 15 Huitzil-Melendez F, Capanu M, Haviland D et al. Evaluation of the impact of systemic (SYS) neoadjuvant chemotherapy (neoadj) in patients (pts) with resectable liver metastasis (mets) from colorectal carcinoma (CRC) treated with adjuvant hepatic arterial infusion (HAI) and SYS chemotherapy. Presented at the 2007 Gastrointestinal Cancers Symposium, Orlando, FL, January 21, 2007. Hurwitz HI, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350: 2335-2342. Chang, J. et al. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer 2000, 89, 2145–2152. Chapman WC, Debelak JP, Wright Pinson C, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000;231:752–761. Chapman WC, Debelak JP, Blackwell TS, et al. Hepatic cryoablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000;135:672–673. Chen P, Wang J, Hope K, et al. Nuclear localizing sequences (NLS) promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. J Nucl Med. 2006;47:827–836. Chiannilkulchai N, Ammoury N, Caillou B, et al. Hepatic tissue distribution of doxorubicin-loaded particles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother. Pharmacol. 1990, 26: 122–126. Church J et al.: Characteristics of management of dominant inherited colorectal carcinoma. DCR 2003, 46(8),1001-5 Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999, 29: 1099-1105 Jager, P. L. et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J. Nucl. Med. 2001, 42, 432–445. Jain RK, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307: 58-62 Jersenius U., Fors D., Rubertsson S, Arvidsson D. Laparoscopic parenchymal division of the liver in a porcine model: comparison of the efficacy and safety of three different techniques Surg Endosc 2007; 21: 315-320 Jiao LR, Szyszko T, Al-Nahhas A, et al. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. 2007 Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006, 355: 1253-61 Jung, H. I., Kettunen, M. I., Davletov, B. & Brindle, K. M. Detection of apoptosis using the C2A domain of synaptotagmin, I. Bioconjug. Chem. 2004, 15, 983–987 Kala Z, Kiss I, Válek V, Kysela P, et al. Multidisciplinární přístup k jaterním malignitám ve FN Brno - model onkologické indikační komise. In Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater - Abstrakta. 1. vyd. Plzeň : Euroverlag s.r.o, 2003. s. 18-18. ISBN 80-7177-794-3 Kala Z, Gál R, Procházka V, Kysela P, et al. Minimalizace krevních ztrát u velkých jaterních resekcí. In Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater - Abstrakta. 1. vyd. Plzeň : Euroverlag s.r.o., 2003. s. 19-19 Kala Z, Kysela P, Válek V. Intéret de la radiofréquence dans les résections hépatiques atypiques pour tumeur maligne - Étude préliminaire a propos de 5 cas. Le journal de Coelio-chirurgie 2003, 48: 32-35 Kala Z, Válek V, Kysela, et al. Laparoscopic hepatic resections using heat coagulation necrosis - 3-years experience. Acta Chirurgica Belgica 2003, suppl 103, 5: 47-48, Kam NWS, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl. 2006;45:577–581. Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 2002;20:4466-4471 Kamel IR. State of the art – imagin of the liver. presented at thAnual course in HPB surgery and transplantation. Hammesmith Hospital Campus, October 2007.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53: 457-81. Karoui M, Penna C, Amin-Hashem M et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1–7. Kavolius J, Fong Y, Blumgart LH. Surgical resection of metastatic liver tumors. Surg Oncol Clin North Am 1996;5:337–352. Kemeny N, Huang Y, Cohen AM, et al.Hepatic arterial infusion of chemotherapy after resection of hepatis metastases of colorectal cancer. N Engl J Med 1999, 341: 2039-48 Kemeny N, Jarnagin W, Gonen M et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003;21:3303–3309. Kemeny N, Eid A, Stockman J et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 2005;91:97–101. Karande P, Jain A, Mitragotri S. Natur. Biotechnol. 2004, 22: 192. Kaufmann, B. A. & Lindner, J. R. Molecular imaging with targeted contrast ultrasound. Curr. Opin. Biotechnol. 2007, 18, 11–16. Kelly K, Alencar H, Funovics M, et al. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res. 2004, 64, 6247–6251. Kettunen MI, Brindle KM. Apoptosis detection using magnetic resonance imaging and spectroscopy. Prog. Nucl. Mag. Reson. Spectrosc. 2005, 47, 175–185. Khambata-Ford S, Baselga J, et al. J Clin Oncol. 2007;25:3230-3237 King W, Proffitt J, Morrison L et al.: The role of fluorescence in situ hybridization in molecular diagnostics and disease management. Mol Diagn 2000, 5(4): 309-19, Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28-40 Knight SJ, Flint J.: Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet. 2000, 37(6): 401-9 Kohne, C.M., Schoffski, P., Wilke, H.: Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of a randomised trial in patients with advanced colorectal cancer. J.Clin.Oncol., 1998, 16, 418-426 Koivasalo AM, Lindgren L., Effects of carbon dioxide pneumoperitoneum for laparoscopic cholecystectomy Act. Anaesth. Scand 2000; 9: 834-841 Kondo T. Eur J cancer 2006, 42: 1237-42 Kooby DA, Fong Y, Suriawinata A et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7: 1034–1044. Kunath K, Von Harpe A, Fischer D, Kissel T. Galactose-PEI-DNA complexes fortargeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Release 2003; 88: 159-172 Kunath K, Merdan T, Hegener O, Haeberlein H, Kissel T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 2003; 5: 588-599 Kune GA, Kune S, Field B et al., Survival in patients in large bowel cancer: a population based investigation from Melbourne colorectal cancer study. Dis Colon Rectum 1990, 33, 938-46, Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002, 132: 605-12 Kysela, Petr - Boudný, Jaroslav - Válek, Vlastimil - Ondrášek, Jiří - Kiss, Igor. Locoregional chemotherapy of the liver without the laparotomy. Acta Chirurgica Belgica, Belgie, suppl. 103, 5, od s. 51-51, 1 s. ISSN 001-5458. 2003 Kysela P, Boudný J, Válek V, et al. Náš přístup k regionální chemoterapii jater. In Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater Plzeň 11.-12.6.2003 - Abstrakta. 1. vyd. Plzeň : Euroverlag sro, Bolzanova 5, 320 25Plzeň, 2003. s. 23-23. ISBN 80-7177-794-3. Kysela P, Kala Z, Mannová J. Notes on laparoscopic liver surgery. International workshop on laparoscopic liver surgery, Cluj-Napoca, Romania, 26.3-29.3.2008. Lal G, Gallinger S, Familial adenomatous polyposis. Semin Surg Oncol, 18(4): 314-23, 2000 Lal PBS., Lee KF. Wong J Techniques for liver resection: a review 2007 Surgeon 5; 3:168-74 Lee D, Choi SW, Kim M et al.: Discovery of differentially expressed genes related to histological subtype of hepatocellular carcinoma. Biotechnol prog. 19(3): 1011-5, 2003 Leggett BA, Young JP, Barker M : Peutz-Jeghers syndrome – genetic screening. Expert Rev Anticancer Ther, 3(4): 518-24, 2003 Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radio-frequency ablation of hepatic colorectal metastases. technique, indications results and new promises. Invest Radiol 2004, 39: 689-97 Lentschener C., Ozier Y. Anaesthesia for elective liver resection: some points should be revisited Eur. J. of Anaesthesiology 2002; 19: 780-788 Levi F, Lucchini F, La Vecchia C, Negri E. Trends in mortality from cancer in the European Union 1955-1994. Lancet 1999, 354, 742-3 Lewandowski RJ, Thurston KG, Goin JE et al. 90Y microsphere treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy measured by FDG-PET and CT imaging. J Vasc Interv Radiol 2005, 16: 1641-51 Liersch T, Meller J, Kulle B, et al. Phase II Trial of Carcinoembryonic Antigen Radioimmunotherapy With 131I-Labetuzumab After Salvage Resection of Colorectal Metastases in the Liver: Five-Year Safety and Efficacy Results. Journal of Clinical Oncology. 2005; 23: 6763-6770. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the „test of time aproach“. Cancer 2003, 97: 3027-35 Loeffler JS, Smith AR, Suit HD. The potential role of proton beams in radiation oncology. Semin Oncol. 1997;24:686-695 Lowenberg B, Sonneveld P. Resistance to chemotherapy in acute leukemia. CurrOpin Oncol 1998;10:31-5 Lutsiak, M. E. et al. Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005, 105, 2862–2868. Madoff DC, Abdalla EK, Vauthey EK. portal vein embolisation in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005, 16: 779-90 Madoff DC, Abdalla EK, Gupta S, et al. Transhepatic ipsilateral portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 2005, 16: 215-25. Makuuchi M, Tahi BL, Takayasu K, et al. Preoperative portal viembolisation to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990, 107: 521-7 T. Mala, B. Edwin, I. Gladhaug, E. Fosse, O. Soireide, A. Bergan et al., A comparative study of the short term outcome following open and laparoscopic liver resection of colorectal metastases. Surg Endosc 16 7 (2002), pp. 1059–1063. Mantel N. Evaluation of survival dataand two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 1966, 50 (3): 163-70. Marelli L, Stigliano R, Triantos C, et al.Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25 Marra G, Boland R, : HNPCC: the syndrome, the genes and historical perspectives (review). J of the National Cancer Institute 1995, 87: 1114-1125, Marshall E. What to do when clear success comes with an unclear risk? Science 2002; 298: 510-511 Martin R, Paty P, Fong Y et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197:233–241, discussion 241–242. Matsuzaki Y, Osuga T, Chiba T, et al. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Intern Med. 1995;34:302-304 Mayer R, Mock U, Jäger R, et al.Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother. Oncol. 2004; 73Suppl 2:24-8 McManus MT. Semin. Cancer. Biol. 2003, 13: 253 Meng A, Wang Y, Van Zant G, Zhou D. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res 2003;63:5414-9. Merdan T, Callahan J, Petersen H, et al. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem 2003; 14: 989-996 Meta-Analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998, 16: 301-8 Yüklə 1,31 Mb. Dostları ilə paylaş:
|